The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.

New insights into what causes the painful and disruptive symptoms of urinary tract infections (UTIs) could offer hope for ...

While cannabinoids offer a potential alternative for refractory chronic pain, optimal use requires personalized dosing and ...

ROCKAWAY, N.J. - electroCore, Inc. (NASDAQ:ECOR), a bioelectronic medicine company with a market capitalization of ...

Newel Health has been granted EU medical device certification for its virtual reality-based digital therapeutic (DTx) for chronic pain, clearing the way for a launch in Europe.

The successful financings come amid a more than two-year stretch when the sector has struggled to attract fresh capital with ...

Like yoga mats with coils, these electromagnetic frequency-emitting devices are trending and doctors love them. Here’s the ...

As temperatures drop during the winter season, safety hazards for seniors increase. This is because older adults are more vulnerable to the cold due to slower circulation, lower body fat and ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement ...

Saluda Medical, Inc., a pioneer in the development and commercialization of a novel neuromodulation platform designed to ...

Smart watches, rings, and a growing array of patches are adding more functionality and being used across a growing set of ...

Group One CFO Jesley Chua is helping to take Asia’s largest global sports property to its next stage of evolution.